Kate Goodwin reports:
A global pandemic has left life sciences companies with giant targets on their backs for cyberattacks.
As of December, at least six pharmaceutical companies in the U.S., U.K. and South Korea working on COVID-19 treatments were targeted by North Korean hackers, according to the Wall Street Journal. The hackers were out for sensitive information to sell or weaponize.
Many hospitals running COVID-19 antibody trials have seen at least triple the attempts to access servers compared to previous years. Intelligence agencies have warned health care systems repeatedly about vaccine-related research thefts by nation-state-backed hackers.
Read more on BioSpace.